德英生物科技

Audit Committee Resolutions

Resolutions of the Audit Committee

Date Major Agenda Items Resolutions
114.03.07 Proposal 1: The Company's financial report for Year 113 submitted for review. Upon inquiry by the Chair, all independent directors present agreed to approve the proposal as submitted, and it was forwarded to the Board of Directors for discussion.
Proposal 2: The Company's business report for Year 113 submitted for review. Upon inquiry by the Chair, all independent directors present agreed to approve the proposal as submitted, and it was forwarded to the Board of Directors for discussion.
Proposal 3: The Company's earnings distribution proposal for Year 113 submitted for review. Upon inquiry by the Chair, all independent directors present agreed to approve the proposal as submitted, and it was forwarded to the Board of Directors for discussion.
Proposal 4: Proposal for capitalization of earnings and issuance of new shares submitted for review. Upon inquiry by the Chair, all independent directors present agreed to approve the proposal as submitted, and it was forwarded to the Board of Directors for discussion.
Proposal 5: The Company has completed the self-assessment of the internal control system for Year 113 and intends to issue the Internal Control System Statement; submitted for discussion. Upon inquiry by the Chair, all independent directors present agreed to approve the proposal as submitted, and it was forwarded to the Board of Directors for discussion.
Proposal 6: Assessment report on the suitability of the appointment of the Company's certified public accountants submitted for discussion. Upon inquiry by the Chair, all independent directors present agreed to approve the proposal as submitted, and it was forwarded to the Board of Directors for discussion.
Proposal 7: Evaluation of the independence of the Company's certifying certified public accountants submitted for discussion. Upon inquiry by the Chair, all independent directors present agreed to approve the proposal as submitted, and it was forwarded to the Board of Directors for discussion.
Proposal 8: Proposal to appoint CPAs Hsu Hui-Yu and Yeh Fang-Ting of PricewaterhouseCoopers Taiwan as the Company's auditors for the Year 114 financial reports submitted for discussion. Upon inquiry by the Chair, all independent directors present agreed to approve the proposal as submitted, and it was forwarded to the Board of Directors for discussion.
Proposal 9: Proposal to amend certain articles of the Company's Articles of Incorporation submitted for discussion. Upon inquiry by the Chair, all independent directors present agreed to approve the proposal as submitted, and it was forwarded to the Board of Directors for discussion.
114.05.09 Proposal 1: The Company's financial report for the first quarter of Year 114 submitted for review. Upon inquiry by the Chair, all independent directors present agreed to approve the proposal as submitted, and it was forwarded to the Board of Directors for discussion.
Proposal 2: Proposal to engage PricewaterhouseCoopers Taiwan to conduct the audit and certification of the Year 114 financial statements and profit-seeking enterprise income tax return, the English translation of financial statements, and the preparation of non-managerial full-time employee salary information; submitted for discussion. Upon inquiry by the Chair, all independent directors present agreed to approve the proposal as submitted, and it was forwarded to the Board of Directors for discussion.
Proposal 3: Proposal for the renewal of the "Directors' Liability Insurance" for Year 114 submitted for discussion. Upon inquiry by the Chair, all independent directors present agreed to approve the proposal as submitted, and it was forwarded to the Board of Directors for discussion.

※ On mobile devices, you can swipe left or right to view the full table; on desktop, the full width is displayed without cropping.